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The fruit pulp extract of Tamarindus indica has been reported for its antioxidant and hypolipidemic properties. In this study,
the methanol extract of T. indica fruit pulp was investigated for its effects on the abundance of HepG2 cell lysate proteins.
Cell lysate was extracted from HepG2 cells grown in the absence and presence of the methanol extract of T. indica fruit pulp.
Approximately 2500 spots were resolved using two-dimensional gel electrophoresis and the abundance of 20 cellular proteins
was found to be significantly reduced. Among the proteins of reduced abundance, fourteen, including six proteins involved
in metabolism (including ethanolamine phosphate cytidylyltransferase), four mitochondrial proteins (including prohibitin and
respiratory chain proteins), and four proteins involved in translation and splicing, were positively identified by mass spectrometry
and database search. The identified HepG2 altered abundance proteins, when taken together and analyzed by Ingenuity Pathways
Analysis (IPA) software, are suggestive of the effects of T. indica fruit pulp extract on metabolism and inflammation, which are
modulated by LXR/RXR. In conclusion, the methanol fruit pulp extract of T. indica was shown to cause reduced abundance of
HepG2 mitochondrial, metabolic, and regulatory proteins involved in oxidative phosphorylation, protein synthesis, and cellular
metabolism.
1. Introduction
Tamarindus indica or tamarind is a tropical fruit tree native
to the African savannahs but it can now be found in many
tropical countries. It is categorized as a monospecific genus
in the family of Leguminosae. The sweet and sour taste of its
fruit pulp is used to add flavor to local cuisines. Besides culi-
nary, tamarind is also used in traditionalmedicine as laxative,
diuretic, antibacterial agents as well as in treatment of fever
and malarial infections [1, 2]. Previous biochemical analyses
have demonstrated that extracts of T. indica possess high
antioxidant activities [3, 4]. In addition, T. indica extracts
have also been shown to reduce the levels of blood cholesterol
and triacylglycerol in hypercholesterolemic hamsters [3]
and in humans [5]. However, the molecular mechanisms of
the anti-inflammatory and hypolipidemic effects of the fruit
remain elusive.
In our previous study, the methanol extract of T. indica
fruit pulp was shown to alter the expression of more than a
thousand genes in HepG2 cells, many of which are associated
with lipid metabolism [6]. Our recent study also showed
that the fruit pulp extract was able to alter the secretion
of alpha enolase, apolipoprotein A-1, transthyretin, and rab
GDP dissociation inhibitor beta from HepG2 cells, which
may account for the lipid-lowering effects of the fruit. These
effects were hypothesized to occur via activation of LXR/
RXR [7].
The lipid-lowering properties of T. indica fruit pulp
are likely attributed to the presence of polyphenols in its
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extract. The methanol extract of T. indica fruit pulp con-
tains predominantly proanthocyanidins of various forms,
including (+)-catechin [4, 8] and (−)-epicatechin, along with
taxifolin, apigenin, eriodictyol, luteolin, and naringenin [4].
Proanthocyanidins from grape seeds have been shown to
lower the levels of blood cholesterol and triacylglycerol in
hamsters through excretion of bile [9]. In addition, other
polyphenols like naringenin [10] and tea catechins [11] have
also been shown to have effects on transcriptional regulation
of hepatic lipid metabolism in rats and humans.
In this study, the methanol extract of T. indica fruit pulp
was further investigated for its effects on the abundance
of HepG2 cell lysate proteins by two-dimensional gel elec-
trophoresis and densitometry. Identification of HepG2 cell
lysate proteins that are significantly altered in abundancemay
help to improve our understanding of themetabolic pathways
andmolecular mechanisms that are affected by the fruit pulp.
2. Materials and Methods
2.1. Preparation of Methanol Extract of the T. indica Fruit
Pulp. T. indica fruit pulps were collected at Universiti Putra
Malaysia and the fruits were identified through comparison
with a registered voucher specimen (KLU45976) deposited in
the Herbarium of Institute of Biological Sciences, University
of Malaya. T. indica fruit pulp extract was prepared as
previously described [6], with slight modifications. Briefly,
ripe fruit pulp of T. indica was separated from the seeds,
air-dried and powdered. The powdered fruit pulp (10 g) was
placed in a conical flask and soaked in 200mL methanol
at room temperature. The mixture was then stirred with
a magnetic stirrer for 1 h and kept in the dark for 24 h.
The resulting extract was then filtered and dried in a rotary
evaporator and finally redissolved in 10% DMSO. Samples
were kept at −20∘C until further analysis.
2.2. Cell Culture. Human hepatoma HepG2 cell line (ATCC,
Manassas, VA, USA) was grown in a complete medium
consisting of Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 5mM glucose, 10% foetal bovine serum
(FBS; HyClone, Australia), 0.37% (w/v) sodium bicarbonate
and 0.48% (w/v) HEPES, pH 7.4, in a CO
2
humid incubation
chamber at 37∘C.
2.3. Treatment of HepG2 Cells with T. indica Fruit Pulp Extract
and Preparation of Cell Lysate. HepG2 cells were seeded at
a density of 9.0 × 106 in a 75 cm2 flask for 18–24 h, followed
by extensive washing with phosphate-buffered saline (PBS).
The cells were then incubated for 24 h in serum-free medium
in the presence of 0.02% DMSO (vehicle) as controls or a
final concentration of 60𝜇g/mLmethanol extract of T. indica
fruit pulp. The cells were then lysed in rehydration buffer
(7Murea, 2M thiourea, 2%w/v CHAPS, 0.5% v/v IPG buffer,
orange G, protease inhibitor) and protein concentration of
lysate was determined using the Bradford assay kit (Bio-rad,
Hercules, CA, USA).
2.4. Two-Dimensional Gel Electrophoresis (2D-GE). Forty 𝜇g
of cell lysate proteins were cleaned using the 2D clean-up kit
(GE, Piscataway, USA). The resulting protein pellet was then
reconstituted in rehydration solution containing 7M urea,
2M thiourea, 2% w/v CHAPS, 0.5% v/v IPG buffer, orange G,
and protease inhibitor. Immobiline pH gradient strip (13 cm,
non-linear, pH 3–10, GE Healthcare, Uppsala, Sweden) was
then rehydrated in the reconstituted protein sample for
18 h at room temperature. First dimension separation was
performed on an Ettan IPGphor III (GE, Uppsala, Sweden)
ran on the following conditions: (i) 500V, 1 hr 10mins, step
and hold; (ii) 1000V, 1 hr, gradient; (iii) 8000V, 2 hrs 30mins,
gradient and (iv) 8000V, 55mins, step and hold. The strips
were then equilibrated in SDS equilibration buffer containing
6M urea, 75mM Tris-HCl, pH 8.8, 29.3% v/v glycerol, 2%
w/v SDS, 0.002% w/v bromophenol blue, and 1% w/v dithio-
threitol (DTT) for 15min, followed by a second equilibration
using the same buffer containing 4.5% w/v iodoacetamide
instead of DTT for another 15min. Second dimension sepa-
ration was carried out on 12.0% polyacrylamide gel using the
SE 600Ruby electrophoresis system (GEHealthcare,Uppsala,
Sweden) at a constant voltage of 50V and 40mA/gel for
20min, and then switched to 500V and 40mA/gel until the
bromophenol bluemarker was 1mmaway from the bottomof
the gel. Gels were silver-stained with PlusOne Silver Staining
Kit (GE Healthcare, Uppsala, Sweden) and scanned using the
ImageScanner III (GE Healthcare, Uppsala, Sweden).
2.5. Image and Data Analyses. Gel images were analyzed
using the ImageMaster 2D Platinum V 7.0 software (GE
Healthcare, Uppsala, Sweden). Briefly, the 2D gel images were
subjected to spot detection and quantification in the differ-
ential in-gel analyses module. Protein spots were normalized
using percentage of volume to minimize variations between
gels within the same group. Statistically significance (𝑃 <
0.05, Student’s t-test) and presence in all 6 gels were the two
criteria for acceptance of protein spots of altered abundance.
Selected spots were filtered based on an average expression
level change of at least 1.5-fold.
2.6. In-Gel Tryptic Digestion. Protein spots were excised
manually from 2D-GE gels and washed with 100mM
NH
4
HCO
3
for 15min. The gel plugs were then destained
twice with 15mM potassium ferricyanide/50mM sodium
thiosulphate with shaking. They were then reduced with
10mM DTT at 60∘C for 30min and alkylated with 55mM
iodoacetamide in the dark at room temperature for 20min.
The plugs were later washed thrice with 500𝜇L of 50%
ACN/50mM NH
4
HCO
3
for 20min, dehydrated with 100%
ACN for 15min, and dried using the SpeedVac. The gel plugs
were finally digested in 6 ng/𝜇L trypsin (Pierce, Rockford,
IL USA) in 50mM NH
4
HCO
3
at 37∘C for at least 16 h.
Peptide mixtures were extracted twice with 50% ACN and
100% ACN, respectively, and finally concentrated using the
Speedvac until completely dry. Dried peptides were then kept
at −20∘C or reconstituted with 10 𝜇L of 0.1% TFA, prior to
desalting using the Zip Tip C18 micropipette tips (Millipore,
Billerica, MA, USA).
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2.7. Mass Spectrometry and Database Search. Trypsin digest-
ed peptidemixturewas analyzed using anAppliedBiosystems
4800 Plus MALDI-TOF/TOF (Foster City, CA, USA). The
peptide mixture was crystallized with alpha-cyano-4-
hydroxycinnamic acid matrix solution (10mg/mL, 70% ACN
in 0.1% (v/v) TFA aqueous solution) and spotted onto a
MALDI target (192-well) plate. The MS results were auto-
matically acquiredwith a trypsin autodigest exclusion list and
20 most intense ions were selected for MS/MS analysis. Data
analysis was carried out using the GPS Explorer software
(Applied Biosystems, CA, USA) and database search using
the in-house MASCOT program (Matrix Science, London,
UK). Combined MS and MS/MS searches were conducted
with the following settings: Swiss-Prot database, Homo
sapiens, peptide tolerance at 200 ppm, MS/MS tolerance at
0.4Da, carbamidomethylation of cysteine (variable modifi-
cation) and methionine oxidation (variable modifications).
A protein is considered identified when a MASCOT score
of higher than 55 and 𝑃 < 0.05 were obtained from the MS
analysis.
2.8. Functional Analyses Using Ingenuity Pathways Analysis
(IPA) Software. Functional analyses to predict networks that
are affected by the differentially expressed proteins were
carried out using Ingenuity Pathways Analysis (IPA) software
(Ingenuity Systems, http://www.ingenuity.com/). Details of
the proteins, their quantitative expression values (fold change
difference of at least 1.5) and 𝑃 values (𝑃 < 0.05) were
imported into the IPA software. Each protein identifier
was mapped to its corresponding protein object and was
overlaid onto a global molecular network developed from
information contained in the Ingenuity Knowledge Base.
Network predictions based on the protein input were gener-
ated algorithmically by utilizing the information contained
in the Ingenuity Knowledge Base. Right-tailed Fischer’s exact
test was used to calculate a 𝑃 value indicating the probability
that each biological function assigned to the network is due
to chance alone.
2.9. Validation of Proteins of Reduced Abundance. Three of
the altered proteins, ethanolamine phosphate cytidylyltrans-
ferase (PCYT2) and NADH dehydrogenase (ubiquinone) 1
alpha subcomplex subunit 10 (NDUFA10) and ubiquinol-
cytochrome-c reductase complex core protein 2 (UQCRC2)
were selected for validation using Western blotting. HepG2
cells (3 × 106) were treated with 60𝜇g/mL T. indica fruit pulp
extract for 24 h. The cells were then trypsinized and lysed
with RIPA buffer (150mM NaCl; 50mM Tris-HCl, pH 7.4;
1mMEDTA; 1% Triton X-100; 1% sodium deoxycholate; 0.1%
SDS). Total cell lysate proteins were quantified using BCA
assay kit (Pierce, Rockford, IL, USA). Forty micrograms of
cell lysate protein was separated on a 12.5% SDS-PAGE and
transferred onto a PVDF membrane with 0.45𝜇m pore size
(Thermo Scientific, IL, USA) at 100V, 110mA for 90 minutes.
The blot was then blocked overnight and developed against
anti-PCYT2 (ab126142, rabbit polyclonal, Abcam, UK), anti-
NDUFA10 (ab103026, rabbit polyclonal, Abcam, UK), anti-
UQCRC2 (ab103616, rabbit polyclonal, Abcam, UK), and
Table 1: Average percentage of volume of spots.
Spot ID Average percentage of volume ± SEM
Control Treated
363 0.0273 ± 0.0016 0.0187 ± 0.0019
398 0.0214 ± 0.0021 0.0134 ± 0.0020
540 0.0128 ± 0.0019 0.0073 ± 0.0011
590 0.0892 ± 0.0073 0.0609 ± 0.0039
615 0.0240 ± 0.0023 0.0157 ± 0.0016
637 0.0254 ± 0.0033 0.0156 ± 0.0011
655 0.0499 ± 0.0033 0.0328 ± 0.0056
657 0.0655 ± 0.0088 0.0360 ± 0.0035
675 0.0660 ± 0.0067 0.0440 ± 0.0017
722 0.0223 ± 0.0022 0.0144 ± 0.0014
751 0.0420 ± 0.0038 0.0235 ± 0.0027
765 0.0470 ± 0.0031 0.0315 ± 0.0040
796 0.0162 ± 0.0011 0.0093 ± 0.0009
900 0.0394 ± 0.0048 0.0206 ± 0.0044
914 0.0279 ± 0.0015 0.0177 ± 0.0012
1084 0.0305 ± 0.0015 0.0209 ± 0.0017
1254 0.0154 ± 0.0018 0.0078 ± 0.0007
1355 0.0107 ± 0.0018 0.0054 ± 0.0010
1634 0.0746 ± 0.0125 0.0435 ± 0.0031
1649 0.0639 ± 0.0069 0.0416 ± 0.0032
The protein spots show significant differences in their abundance (𝑃 < 0.05)
in T. indica-treated and nontreated (control) HepG2 cells by more than 1.5-
fold.
anti-beta actin (ab8227, rabbit polyclonal, Abcam, UK) as the
loading control using the WesternDot 625 Goat Anti-Rabbit
Western Blot kit (Invitrogen, Oregon, USA). Quantification
of the band intensity was calculated using ImageJ software.
3. Results
3.1. 2D-GE Analysis of HepG2 Cell Lysate Proteins. Analysis
of HepG2 cell lysate by 2D-GE resolved more than 2500
protein spots in each gel. Figure 1 demonstrates typical 2D-
GE resolved patterns of the cell lysate proteins from controls
and HepG2 cells treated with the fruit pulp extract of T.
indica. The percentage of volume contribution of each spot
was then determined using ImageMaster 2D Platinum V 7.0
software, and the fold change, if any, was acquired. Protein
spots that were present in all gels (𝑛 = 6) and showed
significant differences in their abundance (𝑃 < 0.05) in
treated and nontreated cells by more than 1.5-fold were
selected. Based on these criteria, the altered abundance of 20
protein spots were detected when HepG2 cells were exposed
to the fruit pulp extract of T. indica (Table 1).
3.2. Identification of Altered Abundance HepG2 Cell Lysate
Proteins. Among the 20 protein spots that were significantly
reduced in abundance, 14 were successfully identified by
mass spectrometry and database search (Table 2). Six spots
(protein spot ID 398, 615, 637, 1254, 1355, and 1649) were
considered not successfully identified as their scores were
lower than the cut-off value for positive inclusion criteria.
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Figure 1: A representative proteome map of HepG2 cell lysate. Approximately 2500 spots per gel within the pH 3–10 range for cell lysate of
HepG2 cells were detected. Twenty spots were altered in abundance (circled and labelled) and they were all significantly reduced in abundance
(𝑃 < 0.05).
The 14 identified proteins may be grouped according to
their biological processes using the UniProt Protein Knowl-
edgebase (UniProtKB). NADH dehydrogenase (ubiquinone)
1 alpha subcomplex subunit 10, ubiquinol-cytochrome-c
reductase complex core protein 2, andNADHdehydrogenase
(ubiquinone) flavoprotein 1 were grouped under “mitochon-
drial respiratory chain” category. Three proteins, that is,
eukaryotic translation initiation factor 3 subunit 3, elonga-
tion factor Tu, and tyrosyl-tRNA synthetase, are involved
in “protein synthesis.” Another six proteins were catego-
rized under “metabolism,” with glyceraldehyde-3-phosphate
dehydrogenase and GDP-L-fucose synthetase being involved
in carbohydrate metabolism, GMP reductase 2 and UMP
synthase in nucleotide and nucleosidemetabolism, S-methyl-
5-thioadenosine phosphorylase in polyamine metabolic pro-
cess, and ethanolamine phosphate cytidylyltransferase in
biosynthesis of phospholipids. Prohibitin, on the other hand,
was categorized under “cell proliferation and differentiation,”
while heterogeneous nuclear ribonucleoprotein H3 does not
belong to any of the above groups and therefore categorized
as “others.”
3.3. Biological Processes and Pathway Interaction Analysis.
The cell lysate proteins of altered abundance, when analyzed
using Ingenuity Pathways Analysis (IPA) software, generated
a single network on “Hereditary disorder, metabolic disease,
molecular transport,” with a score of 48 (Table 3). Mitochon-
drial dysfunction was ranked with the highest significance
(𝑃 < 3.65 × 10−4) from a canonical pathway analysis. When
the data was reanalyzed to include our earlier reported results
of HepG2 proteins that were differentially secreted when
the cells were exposed to the T. indica fruit pulp extract
[7], the software identified “Lipid Metabolism, Molecular
Transport and Small Molecule Biochemistry” as top putative
network (score of 31) that links the proteins of altered
abundance with other interactomes, and gluconeogenesis I
became the top canonical pathway (𝑃 < 4.67×10−4) (Table 3).
Figure 2 shows a graphical representation of the predicted
molecular relationships between HepG2 proteins that were
altered in abundance in response to exposure to T. indica
fruit pulp extract. Other than the lipid-related interactomes,
the HepG2 proteins of altered abundance were shown to be
associated with inflammation-related molecules like tumour
necrosis factor (TNF) and interleukin-1 beta (IL-1𝛽). Two
transcription regulators, mediator of RNA polymerase III
transcription subunit 30 (MED30), and transcription factor
E2F1 (E2F1) were also shown to be interconnected with the
proteins.
3.4. Confirmation of the Effects of T. indica Fruit Pulp Extract
on HepG2 Proteins. To validate the effects of the T. indica
fruit pulp extract on HepG2 proteins, Western blotting was
performed using antisera raised against the cellular proteins.
In view of the scarce amount of HepG2 cell lysate protein
extract that was generated in this study, three proteins, that
is, ethanolamine phosphate cytidylyltransferase (PCYT2),
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex
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Table 3: Top network and canonical pathways generated by Ingenuity Pathways Analysis.
Proteins subject
to analysis
Associated network
functions Score
b Top canonical
pathway 𝑃 value
Cell lysate
proteins
Hereditary disorder, metabolic
disease, molecular transport 48
Mitochondrial
Dysfunction 3.65𝐸 − 04
Cell lysate and
secretory
proteinsa
Lipid metabolism, molecular
transport, small molecule
Biochemistry
31 Gluconeogenesis I 4.67𝐸 − 04
a
Earlier reported [7].
bA score of 2 or higher indicates at least a 99% confidence of not being generated by random chance and higher scores indicate a greater confidence.
subunit 10 (NDUFA10), and ubiquinol-cytochrome-c reduc-
tase complex core protein 2 (UQCRC2) that represent those
involved in the mitochondrial and metabolic activities were
selected. Densitometry scanning of bands detected by the
antisera showed that the abundance of PCYT2, NDUFA10,
and UQCRC2 was indeed lower in HepG2 cells treated with
the T. indica fruit pulp extract compared to the controls, with
fold differences of –1.7, –1.5, and –1.5, respectively (Figure 3).
4. Discussion
In this study, the abundance of 20 cell lysate proteins was
found to be significantly reduced when HepG2 cells were
exposed to the T. indica fruit pulp extract. Fourteen of the
proteins were identified by mass spectrometry and database
search, and the reduced abundance of three of the HepG2
proteins was subsequently validated by Western blotting.
Due to limited availability of antibodies and HepG2 cell
lysate protein extract, validation was performed on the
three selective proteins that are representative of separate
mitochondrial functions and metabolic activities.
Among the identified HepG2 proteins, three com-
ponents of the mitochondrial respiratory chain, namely,
ubiquinol-cytochrome-c reductase complex core protein 2
(UQCRC2), NADH dehydrogenase (ubiquinone) 1 alpha
subcomplex subunit 10 (NDUFA10), and NADH dehydroge-
nase (ubiquinone) flavoprotein 1 (NDUFV1), were found to
be reduced in abundance when HepG2 cells were exposed
to T. indica fruit pulp extract. UQCRC2 belongs to complex
III of the mitochondrial respiratory chain while NDUFA10
andNDUFV1 are components of complex I. Inmitochondria,
only complex I [12, 13] and complex III [14] of the respiratory
chain are known to produce reactive oxygen species (ROS).
Hence, the decreased amount of the three mitochondrial
components may indicate reduced production of free rad-
icals, although the functionality of the mitochondria is yet
to be confirmed. Nevertheless, earlier studies in obese rat
muscles have shown that reduced levels of respiratory chain
complex I and diminishedROS production that were induced
by chronic supplementation with grape seed proanthocyani-
dins did not affect the function of the mitochondria [15].
Prohibitin is another mitochondrial protein that was
shown to be of reduced abundance in HepG2 cells exposed
to T. indica fruit pulp extract. The protein that was initially
thought to be a negative regulator of cell proliferation has
been demonstrated to play a role in biogenesis and function of
mitochondria [16]. In a study of the nematodeCaenorhabditis
elegans, prohibitin complex was shown to promote longevity
by modulating mitochondrial function and fat metabolism
[17]. Deficiency of prohibitin prolongs the lifespan of C.
elegans with compromised mitochondrial function or fat
metabolism. In this study, depletion of prohibitin in HepG2
cells upon exposure to the fruit pulp extract of T. indica
appears to suggest a similar mechanism in an attempt to
extend lifespan of the cells.
In addition to the mitochondrial proteins, the gly-
colytic enzyme glyceraldehyde 3-phosphate dehydrogenase
(GAPDH), as well as GDP-L-fucose synthetase (TSTA3), also
appeared to be down-regulated after treatment with T. indica
fruit pulp extract. Oxidative stress is known to induce up-
regulation of GAPDH levels [18, 19]. Hence, the reduced
amount of GAPDH in this case may possibly indicate a
state of repressed oxidative stress. This, together with the
earlier data on the reduced mitochondrial respiratory chain
proteins, may shed some light on molecular mechanisms
involved in the well acclaimed antioxidant properties of T.
indica [3, 4].
The fruit pulp extract of T. indica also appeared to
cause decreased abundance of proteins involved in the
metabolism of nucleic acids and polyamines in HepG2 cells.
To the best of our knowledge, these have not been previ-
ously reported and their rationale is not quite understood.
On the other hand, decreased abundance of ethanolamine
phosphate cytidylyltransferase (PCYT2), the rate-limiting
enzymewhich catalyzes conversion of phosphoethanolamine
to cytidylylphosphoethanolamine in the biosynthesis of
phosphatidylethanolamine, in HepG2 cells exposed to the
fruit extract of T. indica may compromise availability of
the phospholipid, which stores arachidonic acid for the
production of prostaglandins.This could possibly explain the
anti-inflammatory action ofT. indica thatwas earlier reported
[20].
In addition, eukaryotic translation initiation factor 3 sub-
unit 3 (eIF3H), tyrosyl-tRNA synthetase (YARS), elongation
factor Tu (EFTU), and heterogenous nuclear ribonucleopro-
tein H3 (hnRNPH3), which are generally involved in protein
synthesis and splicing, also appeared to be down-regulated in
HepG2 cells treated with the T. indica extract. These proteins
may be key regulatory points of action of the fruit pulp extract
of T. indica. Suppression of these proteins by the extract may
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Figure 2: IPA graphical representation of the molecular rela-
tionships between HepG2 secreted and cytosolic proteins after
treatment. The network is displayed graphically as nodes (proteins)
and edges (the biological relationships between the nodes). Nodes
in red indicate up-regulated proteins while those in green represent
down-regulated proteins. Nodes without colors indicate unaltered
expression. Various shapes of the nodes represent functional class
of the proteins. Edges are displayed with various labels that describe
the nature of the relationship between the nodes. Transthyretin,
TTR; thyroglobulin, TG; interleukin-1 beta, IL1B; tumour necro-
sis factor, TNF; apolipoprotein A-1, APOA1; apolipoprotein C-
1, APOC1; lecithin cholesterol acyltransferase, LCAT; endothe-
lial lipase, LIPG; haptoglobin, HP; phospholipase A2, PLA2G2A;
cholesterylester transfer protein, CETP; ATP-binding cassette trans-
porter sub-family C member 9, ABCC9; ATP-sensitive inward
rectifier potassium channel 11, KCNJ11; ectonucleotide pyrophos-
phatase/phosphodiesterase family member 1, ENPP1; amyloid pre-
cursor protein, APP; glyceraldehyde-3-phosphate dehydrogenase,
GAPDH; alpha enolase, ENO1; adenylate kinase, AK1; ubiquinol-
cytochrome-c reductase complex core protein 2,UQCRC2; xanthine
dehydrogenase, XDH; cystathionine beta-synthase, CBS; methio-
nine adenosyltransferase I, alpha, MAT1A; rab GDP dissociation
inhibitor beta, GDI2; NLR (nucleotide-binding domain and leucine
rich repeat containing family) family, pyrin domain containing
3, NLRP3; Vacuolar ATP synthase subunit E, ATP6V1E1; elonga-
tion factor Tu, TUFM; prohibitin, PHB; choline-phosphate cytidy-
lyltransferase A, PCYT1A; uridine 5󸀠-monophosphate synthase,
UMPS; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex
subunit 10, NDUFA10; NADH dehydrogenase (ubiquinone) flavo-
protein 1, NDUFV1; mediator of RNA polymerase III transcription
subunit 30, MED30; transcription factor E2F1, E2F1; suppressor of
G2 allele of SKP1 homolog, SUGT1.
reflect the underlying epigenetic mechanism that ultimately
caused the reduced expression of all the mitochondrial and
metabolic proteins and enzymes.
Subjecting the altered abundance proteins to IPA anal-
ysis generated a single network on “Hereditary disor-
der, metabolic disease, molecular transport,” which ranked
mitochondrial dysfunction with the highest significance
(𝑃 < 3.65 × 10−4). However, “Lipid Metabolism, Molecular
Transport, Small Molecule Biochemistry” became the top
network involved when IPA was reanalyzed to include pro-
teins that were previously shown to be differentially secreted
by HepG2 cells treated with the same fruit extract [7]. This
network was not generated in the earlier analysis as PCYT2
was the sole cellular protein involved in lipidmetabolism that
was affected whenHepG2 cells were exposed to T. indica fruit
pulp extract. In our earlier IPA analysis of secreted proteins of
altered abundance fromHepG2 exposed to the T. indica fruit
pulp extract, a score of 9 was obtained [7], and this improved
to 31 when the data were reanalyzed to include cell lysate
proteins of reduced abundance, signifying markedly higher
probability. In addition, the IPA software also identified
tumour necrosis factor (TNF) and interleukin-1 beta (IL-1𝛽),
both of which are potent inflammatory mediators, as inter-
actomes in the network affected by T. indica (Figure 2). This
further supports our earlier speculation on the molecular
mechanism involved in anti-inflammatory effects ofT. indica.
The lipid-lowering effects induced by plant polyphenols
have been reported by many. In fact, there is an upcoming
trend of research revealing the potentials of plant polyphenols
in regulating in vitro and in vivo metabolic processes. The
methanolic extract of T. indica fruit pulp contains proan-
thocyanidins, which constitutes more than 73% of its total
phenolic content [4]. Proanthocyanidinmodulates activation
of LXRs [9], which are oxysterol-activated nuclear receptors
that control cholesterol homeostasis bymodifying expression
of genes involved in cholesterol absorption and efflux from
peripheral tissues. This process is mediated through ABCA-
1-mediated cholesterol efflux andABCG5/8-mediated choles-
terol excretion and absorption. Interestingly, LXRs also reg-
ulate genes essentially involved in inflammation (Figure 2).
As speculated earlier, the anti-inflammatory action of T.
indica fruit pulpmay possibly occur by inhibition of synthesis
of phospholipids and hence depleting the arachidonic acid
reservoir for the generation of prostanoid inflammatory
mediators.
5. Conclusion
The methanol fruit pulp extract of T. indica was shown
to cause reduced abundance of HepG2 mitochondrial,
metabolic, and regulatory proteins involved in oxidative
phosphorylation, protein synthesis, and cellular metabolism.
The cellular proteins, when taken together with the earlier
HepG2 secreted proteins of altered abundance, are suggestive
of the effects of the fruit pulp extract of T. indica on
inflammation and lipid metabolism, which are modulated by
LXRs.
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Figure 3:Western blot analyses of NDUFA10, PCYT2, and UQCRC2 of HepG2 cells. (a)Western blot cropped images of NDUFA10, PCYT2,
UQCRC2, and beta actin bands detected by antisera against the respective proteins; (b) densitometry analyses of Western blot using ImageJ
software. Assay was done in triplicate and data are represented as mean ± standard deviation.
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